11085607 · Active · incorporated 8 years, 10 months ago · London
Biotech Biotech & Life Sciences Drug Discovery Series A
A biotechnology company focused on researching and developing cancer treatments, specifically targeting voltage-gated sodium channels.
https://www.celexoncology.com/
Celex Oncology is a private limited company registered at Companies House under number 11085607, incorporated on 28 November 2017, with a registered office in London. Its current status on the register is active. Its filed nature of business is manufacture of basic pharmaceutical products (SIC 21100). Sonde has indexed 112 filings for this company, including 5 funding rounds. Its most recent round closed in January 2025, raising £1m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 5 | Jan 2025 | £1m | £0.7455 |
| Round 4 | Mar 2024 | £1.6m | £0.7456 |
| Round 3 | Feb 2024 | £470k | £1.13 |
| Round 2 | Oct 2022 | £825k | £2.50 |
| Round 1 | Sep 2019 | £60k | £1.67 |
Showing the 10 most recent of 112 filings.
See the complete cap table with every shareholder, founder tags, dilution across 52 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.